Literature DB >> 33257848

Mutation-selection balance and compensatory mechanisms in tumour evolution.

Erez Persi1, Yuri I Wolf2, David Horn3, Eytan Ruppin4, Francesca Demichelis5,6, Robert A Gatenby7, Robert J Gillies8, Eugene V Koonin9.   

Abstract

Intratumour heterogeneity and phenotypic plasticity, sustained by a range of somatic aberrations, as well as epigenetic and metabolic adaptations, are the principal mechanisms that enable cancers to resist treatment and survive under environmental stress. A comprehensive picture of the interplay between different somatic aberrations, from point mutations to whole-genome duplications, in tumour initiation and progression is lacking. We posit that different genomic aberrations generally exhibit a temporal order, shaped by a balance between the levels of mutations and selective pressures. Repeat instability emerges first, followed by larger aberrations, with compensatory effects leading to robust tumour fitness maintained throughout the tumour progression. A better understanding of the interplay between genetic aberrations, the microenvironment, and epigenetic and metabolic cellular states is essential for early detection and prevention of cancer as well as development of efficient therapeutic strategies.

Entities:  

Mesh:

Year:  2020        PMID: 33257848     DOI: 10.1038/s41576-020-00299-4

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  185 in total

1.  Mutation selection and the natural history of cancer.

Authors:  J Cairns
Journal:  Nature       Date:  1975-05-15       Impact factor: 49.962

2.  Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies.

Authors:  Utthara Nayar; Ofir Cohen; Christian Kapstad; Michael S Cuoco; Adrienne G Waks; Seth A Wander; Corrie Painter; Samuel Freeman; Nicole S Persky; Lori Marini; Karla Helvie; Nelly Oliver; Orit Rozenblatt-Rosen; Cynthia X Ma; Aviv Regev; Eric P Winer; Nancy U Lin; Nikhil Wagle
Journal:  Nat Genet       Date:  2018-12-10       Impact factor: 38.330

3.  Instability of short tandem repeats (microsatellites) in human cancers.

Authors:  R Wooster; A M Cleton-Jansen; N Collins; J Mangion; R S Cornelis; C S Cooper; B A Gusterson; B A Ponder; A von Deimling; O D Wiestler
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

4.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

Review 5.  A view on drug resistance in cancer.

Authors:  José Baselga; David M Hyman; Neil Vasan
Journal:  Nature       Date:  2019-11-13       Impact factor: 49.962

6.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

7.  Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.

Authors:  Himisha Beltran; Davide Prandi; Juan Miguel Mosquera; Matteo Benelli; Loredana Puca; Joanna Cyrta; Clarisse Marotz; Eugenia Giannopoulou; Balabhadrapatruni V S K Chakravarthi; Sooryanarayana Varambally; Scott A Tomlins; David M Nanus; Scott T Tagawa; Eliezer M Van Allen; Olivier Elemento; Andrea Sboner; Levi A Garraway; Mark A Rubin; Francesca Demichelis
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

8.  Quantitative evidence for early metastatic seeding in colorectal cancer.

Authors:  Zheng Hu; Jie Ding; Zhicheng Ma; Ruping Sun; Jose A Seoane; J Scott Shaffer; Carlos J Suarez; Anna S Berghoff; Chiara Cremolini; Alfredo Falcone; Fotios Loupakis; Peter Birner; Matthias Preusser; Heinz-Josef Lenz; Christina Curtis
Journal:  Nat Genet       Date:  2019-06-17       Impact factor: 38.330

9.  Clonal evolution of chemotherapy-resistant urothelial carcinoma.

Authors:  Bishoy M Faltas; Davide Prandi; Scott T Tagawa; Ana M Molina; David M Nanus; Cora Sternberg; Jonathan Rosenberg; Juan Miguel Mosquera; Brian Robinson; Olivier Elemento; Andrea Sboner; Himisha Beltran; Francesca Demichelis; Mark A Rubin
Journal:  Nat Genet       Date:  2016-10-17       Impact factor: 38.330

10.  Systematic discovery of complex insertions and deletions in human cancers.

Authors:  Kai Ye; Jiayin Wang; Reyka Jayasinghe; Eric-Wubbo Lameijer; Joshua F McMichael; Jie Ning; Michael D McLellan; Mingchao Xie; Song Cao; Venkata Yellapantula; Kuan-lin Huang; Adam Scott; Steven Foltz; Beifang Niu; Kimberly J Johnson; Matthijs Moed; P Eline Slagboom; Feng Chen; Michael C Wendl; Li Ding
Journal:  Nat Med       Date:  2015-12-14       Impact factor: 53.440

View more
  14 in total

Review 1.  Tumour immunotherapy: lessons from predator-prey theory.

Authors:  Phineas T Hamilton; Bradley R Anholt; Brad H Nelson
Journal:  Nat Rev Immunol       Date:  2022-05-05       Impact factor: 53.106

2.  SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis.

Authors:  Wilfred Leung; Matt Teater; Ceyda Durmaz; Cem Meydan; Alexandra G Chivu; Amy Chadburn; Edward J Rice; Ashlesha Muley; Jeannie M Camarillo; Jaison Arivalagan; Ziyi Li; Christopher R Flowers; Neil L Kelleher; Charles G Danko; Marcin Imielinski; Sandeep S Dave; Scott A Armstrong; Christopher E Mason; Ari M Melnick
Journal:  Cancer Discov       Date:  2022-07-06       Impact factor: 38.272

3.  Analysis of Mutations and Dysregulated Pathways Unravels Carcinogenic Effect and Clinical Actionability of Mutational Processes.

Authors:  Zedong Jiang; Gaoming Liao; Yiran Yang; Yujia Lan; Liwen Xu; Min Yan; Yao Zhou; Jiali Zhu; Wei Liu; Jing Bai; Yun Xiao; Xia Li
Journal:  Front Cell Dev Biol       Date:  2021-11-24

4.  Maintenance of genome sequence integrity in long- and short-lived rodent species.

Authors:  Lei Zhang; Xiao Dong; Xiao Tian; Moonsook Lee; Julia Ablaeva; Denis Firsanov; Sang-Goo Lee; Alexander Y Maslov; Vadim N Gladyshev; Andrei Seluanov; Vera Gorbunova; Jan Vijg
Journal:  Sci Adv       Date:  2021-10-27       Impact factor: 14.136

Review 5.  What do cellular responses to acidity tell us about cancer?

Authors:  Wiktoria Blaszczak; Pawel Swietach
Journal:  Cancer Metastasis Rev       Date:  2021-11-30       Impact factor: 9.264

6.  Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer.

Authors:  Yari Ciani; Tarcisio Fedrizzi; Davide Prandi; Francesca Lorenzin; Alessio Locallo; Paola Gasperini; Gian Marco Franceschini; Matteo Benelli; Olivier Elemento; Luca L Fava; Alberto Inga; Francesca Demichelis
Journal:  Cell Syst       Date:  2021-11-02       Impact factor: 10.304

7.  Targeting IL8 as a sequential therapy strategy to overcome chemotherapy resistance in advanced gastric cancer.

Authors:  Huning Jiang; Jiahua Cui; Hao Chu; Tingting Xu; Mengyan Xie; Xinming Jing; Jiali Xu; Jianwei Zhou; Yongqian Shu
Journal:  Cell Death Discov       Date:  2022-04-29

8.  Acid-base transporters and pH dynamics in human breast carcinomas predict proliferative activity, metastasis, and survival.

Authors:  Nicolai J Toft; Trine V Axelsen; Helene L Pedersen; Marco Mele; Mark Burton; Eva Balling; Tonje Johansen; Mads Thomassen; Peer M Christiansen; Ebbe Boedtkjer
Journal:  Elife       Date:  2021-07-05       Impact factor: 8.140

9.  Genetic alteration and clonal evolution of primary glioblastoma into secondary gliosarcoma.

Authors:  Jie Li; Yu-Hang Zhao; Su-Fang Tian; Cheng-Shi Xu; Yu-Xiang Cai; Kai Li; Yan-Bing Cheng; Ze-Fen Wang; Zhi-Qiang Li
Journal:  CNS Neurosci Ther       Date:  2021-10-04       Impact factor: 5.243

10.  Bridging Tumorigenesis and Therapy Resistance With a Non-Darwinian and Non-Lamarckian Mechanism of Adaptive Evolution.

Authors:  Francesco Catania; Beata Ujvari; Benjamin Roche; Jean-Pascal Capp; Frédéric Thomas
Journal:  Front Oncol       Date:  2021-09-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.